Camber Pharmaceuticals Launches Generic Gralise®

Camber Pharmaceuticals is pleased to announce the addition of Gabapentin Tablets (generic for Gralise®) to its current portfolio. Camber already offers Gabapentin Tablets and Capsules (generic for Neurontin®). Generics for Gralise® and Neurontin® are not interchangeable.
Gabapentin Tablets (generic for Gralise®) are indicated for the management of Postherpetic Neuralgia (PHN).
Gabapentin Tablets (generic for Gralise®) 300 mg and 600 mg are available in 90 count bottles.
To find out more about Gabapentin Tablets, please visit https://www.camberpharma.com/gabapentintablets-gralise
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year